Familial Aggregation of Hodgkin Lymphoma and Related Tumors

Cancer

Volumn 100, Issue 9, 2004, Pages 1902-1908

  Goldin, Lynn R ^a   Pfeiffer, Ruth M ^a   Gridley, Gloria ^a   Gail, Mitchell H ^a   Li, Xinjun ^b   Mellemkjaer, Lene ^c   Olsen, Jørgen H ^c   Hemminki, Kari ^b,d   Linet, Martha S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Case control study; Familial aggregation; Hodgkin lymphoma; Linked registries; Lymphoproliferative tumors

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DENMARK; FAMILY; FEMALE; HEREDITY; HODGKIN DISEASE; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MODEL; NONHODGKIN LYMPHOMA; ONSET AGE; PARENT; POPULATION; PRIORITY JOURNAL; PROGENY; RELATIVE; SIBLING; SWEDEN; TUMOR;

ADOLESCENT; ADULT; AGE OF ONSET; CASE-CONTROL STUDIES; DENMARK; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEMATOLOGIC NEOPLASMS; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; PEDIGREE; PREVALENCE; PROBABILITY; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; SEX DISTRIBUTION; SWEDEN;

EID: 1942466610     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20189     Document Type: Article

References (26)

1. Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001.
2. Ries LA, Eisner MP, Kosary CL, et al., editors. SEER cancer statistics review, 1975-2000 [monograph online]. Bethesda: National Cancer Institute, 2003. Available from URL: http://seer.cancer.gov/csr/1975_2000/ [accessed Dec 9, 2003].
3. Mueller NE. Hodgkin's disease. In: Schottenfield D, Fraumeni JF Jr., editors. Cancer epidemiology and prevention (2nd edition). New York: Oxford University Press, 1996:893-919.
4. Grufferman S, Cole P, Smith PG, Lukes RJ. Hodgkin's disease in siblings. N Engl J Med. 1977;296:248-250.
5. Haim N, Cohen Y, Robinson E. Malignant lymphoma in first-degree blood relatives. Cancer. 1982;49:2197-2200.
6. Kerzin-Storrar L, Faed MJ, MacGillivray JB, Smith PG. Incidence of familial Hodgkin's disease. Br J Cancer. 1983;47: 707-712.
7. Mack TM, Cozen W, Shigbata DK, et al. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med. 1995;332:413-418.
8. Bernard SM, Cartwright RA, Darwin CM, et al. Hodgkin's disease: case control epidemiological study in Yorkshire. Br J Cancer. 1987;55:85-90.
9. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst. 1994;86:1600-1608.
10. Westergaard T, Melbye M, Pedersen JB, Frisch M, Olsen JH, Andersen PK. Birth order, sibship size and risk of Hodgkin's disease in children and young adults: a population-based study of 31 million person-years. Int J Cancer. 1997;2:977-981.
11. Paltiel O, Schmit T, Adler B, et al. The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-Hodgkin lymphoma. Cancer. 2000;88:2357-2366.
12. Shugart YY, Hemminki K, Vaittinen P, Kingman A, Dong C. A genetic study of Hodgkin's lymphoma: an estimate of heritability and anticipation based on the Familial Cancer Database in Sweden. Hum Genet. 2000;106:553-556.
13. Lindelof B, Eklund G. Analysis of hereditary component of cancer by use of a familial index by site. Lancet. 2001;358: 1695-1698.
14. Hemminki K, Li X, Czene K. Familial risk of cancer: data for clinical counseling and cancer genetics. Int J Cancer. 2004; 108:109-114.
15. Hemminki K, Li X, Plna L, Granstrom C, Vaittinen P. The nation-wide Swedish Family Cancer Database. Acta Oncol. 2001;40:772-777.
16. Liang KY. Estimating effects of probands' characteristics on familial risk: 1. Adjustment for censoring and correlated ages at onset. Genet Epidemiol. 1991;8:329-338.
17. Pfeiffer RM, Goldin LR, Chatterjee N, et al. Methods for testing familial aggregation of diseases in population-based samples: Application to Hodgkin lymphoma in Swedish registry data. Ann Hum Genet. In press.
18. Wei LJ, Lin DY, Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Stat Assoc. 1989;84:1065-1073.
19. Hjalgrim H, Askling J, Pukkala E, Hansen S, Munksgaard L, Frisch M. Incidence of Hodgkin's disease in Nordic countries. Lancet. 2001;58:297-298.
20. Glaser SL, Swartz WG. Time trends in Hodgkin's disease incidence. The role of diagnostic accuracy. Cancer. 1990;6: 2196-2204.
21. Jaffe ES, Zarate-Osorno A, Kingma DW, Raffeld M, Medeiros LJ. The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomas. Ann Oncol. 1994;5 Suppl 1:S7-S11.
22. Dores GM, Metayer C, Curtis RE, et al. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol. 2002;20:3484-3494.
23. Travis LB, Curtis RE, Glimelius B, et al. Second cancers among long-term survivors of non-Hodgkin's lymphoma. J Natl Cancer Inst. 1993;85:1932-1937.
24. Seymour J, Campbell J. Richter's syndrome. In: Cheson BD, editor. Chronic lymphoid leukemias (2nd edition). Basel: Marcel Dekker, 2001:459-483.
25. Winther JF, Sankila R, Boice JD, et al. Cancer in siblings of children with cancer in the Nordic countries: a population-based cohort study. Lancet. 2001;358:711-717.
26. Harty LC, Lin AY, Goldstein AM, et al. HLA-DR, HLA-DQ, and TAP genes in familial Hodgkin disease. Blood. 2002;99: 690-693.